Opinion
The NIH and FDA nominees are surprisingly strong
Watching last week’s confirmation hearings for Jayanta Bhattacharya and Marty Makary, President Donald Trump’s nominees to lead the National Institutes of Health and the Food and Drug Administration, respectively, I was struck by how normal the candidates were.
Jay Bhattacharya, nominee for National Institutes of Health director, and FDA pick Marty Makary clear key Senate committee.
Senators who once denounced the NIH nominee’s ideas as “fringe” had nothing to say about pandemic lockdowns, mandates, or ...
"Journalist" Paul Thacker defends Dr. Jay Bhattacharya and the Great Barrington Declaration by rehashing the same old ...
Stanford University professor Jay Bhattacharya appeared before the Senate Committee on Health, Education, Labor, and Pensions for his confirmation hearing as the next director of the National ...
Trump's nominee for NIH director once stirred major controversy for criticizing lockdowns, mask mandates, and school closures ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Weeks into the Covid pandemic, a South African named Nick Hudson, who describes himself as an actuary, private equity ...
The fallout of school lockdowns will be felt for decades. But the Beltway establishment, in a frenzy, wanted to keep America ...
As Marty Makary and Jay Bhattacharya sail through the Senate health committee vote, Weldon's confirmation hearing is canceled ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback